VBLT - ヴァスキュラ―・バイオジェニックス (Vascular Biogenics Ltd.)

VBLTのニュース

   SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vascular Biogenics Ltd. - VBLT  2021/06/16 09:00:00 Business Insider Markets
NEW YORK, June 16, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Vascular Biogenics Ltd. ("VBL" or the "Company") (NASDAQ: VBLT). Such investors are advised to contact Robert S. Willoughby at
   Analysts Are Bullish on Top Healthcare Stocks: Vascular Biogenics (VBLT), Eli Lilly & Co (LLY)  2021/06/15 12:25:09 Smarter Analyst
Theres a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vascular Biogenics (VBLT) and Eli The post Analysts Are Bullish on Top Healthcare Stocks: Vascular Biogenics (VBLT), Eli Lilly & Co (LLY) appeared first on Smarter Analyst .
   Vascular Biogenics trades lower after an update on ovarian cancer study  2021/06/15 11:37:07 Seeking Alpha
   Analysts Are Bullish on These Healthcare Stocks: Coherus Biosciences (CHRS), Vascular Biogenics (VBLT)  2021/06/04 10:25:19 Smarter Analyst
Theres a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Coherus Biosciences (CHRS), Vascular Biogenics The post Analysts Are Bullish on These Healthcare Stocks: Coherus Biosciences (CHRS), Vascular Biogenics (VBLT) appeared first on Smarter Analyst .
   Vascular Biogenics (VBLT) Receives a New Rating from a Top Analyst  2021/06/03 16:55:08 Smarter Analyst
In a report released today, Kevin DeGeeter from Oppenheimer assigned a Buy rating to Vascular Biogenics (VBLT), with a price target of $5.50. The post Vascular Biogenics (VBLT) Receives a New Rating from a Top Analyst appeared first on Smarter Analyst .
   Vascular Biogenics Will stock surge before Earnings results? Stock market Insights & financial analysis  2021/03/17 06:08:00 Stock Market Daily
Vascular Biogenics announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Thinking about buying stock in Super League Gaming, Soligenix, Vascular Biogenics, BioLineRx, or electroCore?  2021/03/04 13:31:00 PR Newswire
NEW YORK, March 4, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SLGG, SNGX, VBLT, BLRX, and ECOR. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO  2021/02/24 12:30:10 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 23) AxoGen, Inc (NASDAQ: AXGN ) (reacted to its fourth-quarter results) Gemini Therapeutics Inc (NASDAQ: GMTX ) Orthofix Medical Inc (NASDAQ: OFIX ) Solid Biosciences Inc (NASDAQ: SLDB ) Vascular Biogenics Ltd (NASDAQ: VBLT ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Feb. 23) AbCellera Biologics Inc (NASDAQ: ABCL ) Acutus Medical Inc (NASDAQ: AFIB ) Bioventus (NASDAQ: BVS ) bluebird bio Inc (NASDAQ: BLUE ) Evaxion Biotech A/S – ADR (NASDAQ: EVAX ) Imara Inc (NASDAQ: IMRA ) Kinnate Biopharma Inc (NASDAQ: KNTE ) Neurobo Pharmaceuticals Inc (NASDAQ: NRBO ) Pharming Group (NASDAQ: PHAR ) Sana Biotechnology Inc (NASDAQ: SANA ) Sarepta Therapeutics Inc (NASDAQ: SRPT ) Talis Biomedical Corp (NASDAQ: TLIS ) Vallon Pharmaceuticals Inc (NASDAQ: VLON ) Virpax Pharmaceuticals Inc (NASDAQ: VRPX ) Voyager Therapeutics Inc (NASDAQ: VYGR ) Stocks In Focus Bausch Health Agrees to Induct Icahn Group Nominees to its Board Bausch Health Companies Inc (NYSE: BHC ) said it will expand its board to add two designees from Carl Icahn and affiliated entities.
   65 Stocks Moving In Tuesday's Mid-Day Session  2021/02/23 12:18:00 Benzinga
Gainers Yunhong CTI Ltd. (NASDAQ: CTIB) shares jumped 64.1% to $3.8899. Vascular Biogenics Ltd. (NASDAQ: VBLT) gained 37.7% to $3.07. Vascular Biogenics, on …
   48 Stocks Moving in Tuesday's Pre-Market Session  2021/02/23 07:02:00 Benzinga
Gainers Vascular Biogenics Ltd. (NASDAQ: VBLT) rose 67.3% to $3.73 in pre-market trading. Vascular Biogenics, on Monday, announced that the Data Safety …
   Vascular Biogenics Ltd. (NASDAQ:VBLT) Expected to Post Earnings of -$0.13 Per Share  2020/11/16 17:24:42 Transcript Daily
Analysts expect Vascular Biogenics Ltd. (NASDAQ:VBLT) to announce earnings per share of ($0.13) for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for Vascular Biogenics’ earnings. The highest EPS estimate is ($0.12) and the lowest is ($0.14). Vascular Biogenics posted earnings of ($0.14) per share in the same quarter last year, […]
   Vascular Biogenics: Q3 Earnings Insights  2020/11/16 07:11:00 Benzinga
Shares of Vascular Biogenics (NASDAQ:VBLT) moved higher by 0.8% in pre-market trading after the company reported Q3 results. Quarterly …
   Vascular Biogenics (VBLT) Reports Q1 Loss, Tops Revenue Estimates  2020/05/14 12:25:08 Zacks Investment Research
Vascular Biogenics (VBLT) delivered earnings and revenue surprises of 6.25% and 89.64%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
   The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom to Join S&P 500  2020/05/07 11:41:00 Benzinga Feeds
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs May 6.) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) (reacted to its first-quarter results and clinical pipeline update) AstraZeneca plc (NYSE: AZN ) ( announced FDA approval for label expansion for its Farxiga) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) BIO-TECHNE Corp (NASDAQ: TECH ) Catalent Inc (NYSE: CTLT ) Cytosorbents Corp (NASDAQ: CTSO ) (reacted to its strong first-quarter results) DexCom, Inc. (NASDAQ: DXCM ) GENMAB A/S/S ADR (NASDAQ: GMAB ) (announced first-quarter results) Horizon Therapeutics PLC (NASDAQ: HZNP ) (reacted to first-quarter results) I mara Inc (NASDAQ: IMRA ) Immunomedics, Inc. (NASDAQ: IMMU ) Immunovant Inc (NASDAQ: IMVT ) Kala Pharmaceuticals Inc (NASDAQ: KALA ) MacroGenics Inc (NASDAQ: MGNX ) (reacted to its first-quarter results and sell-side reactions to the results) Masimo Corporation (NASDAQ: MASI ) Meridian Bioscience, Inc.
   -$0.14 Earnings Per Share Expected for Vascular Biogenics Ltd (NASDAQ:VBLT) This Quarter  2019/11/16 01:10:25 Modern Readers
Equities analysts expect that Vascular Biogenics Ltd (NASDAQ:VBLT) will report ($0.14) earnings per share (EPS) for the current quarter, Zacks reports. Two analysts have issued estimates for Vascular Biogenics’ earnings. Vascular Biogenics posted earnings of ($0.10) per share during the same quarter last year, which would indicate a negative year over year growth rate of […]

calendar